2007-2008 Support from Pharmaceutical Companies and Device Manufacturers

We value the trust placed in us by our donors, supporters and the general public, and we feel the best way to continue to earn that trust is to make the association’s finances as transparent as possible. In fact, the American Heart Association has consistently met the high standards of the Better Business Bureau’s Wise Giving Alliance (WGA)(link opens in new window), the premier organization evaluating charitable organizations.

Most of the revenue recorded by the American Heart Association comes from individual donors who pay their donations to the association during the year and from single and multi-year commitments from individuals and corporations.

Financial support from corporations allows the American Heart Association’s programs and campaigns to more effectively advance our mission to build healthier lives, free of cardiovascular diseases and stroke. All corporate relationships are required to comply with the association’s corporate relations policies and receive approval from two committees representing national volunteers and executive staff.

Corporate revenue received by the National Center from the pharmaceutical companies and device manufacturers listed represents approximately 2.2 percent of the association’s $641,646,000 in total revenue (2007-2008 audited financial statements).

Pharmaceutical and Medical Device Income (National Center Only) $14,205,689
 Other Sources of Income (AHA Association-wide) $627,440,311
  $641,646,000

Pie Chart

The pie chart above illustrates the amount of National Center revenues from pharmaceutical companies and device manufacturers compared to all sources of income.

Listed below at left is cash received by the American Heart Association's National Center from Pharmaceutical Companies and Device Manufacturers for fiscal year 2007-2008.

In addition, at right we have listed funds committed to the American Heart Association in fiscal year 2007-2008 that will be paid over the next few years. Examples of these types of funds include multi-year sponsorship of an American Heart Association program or campaign.

Table 09